Pharmaceuticals

• Asthma And Copd Drugs Market By Drug Class (bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs) And Indication (asthma And Copd) - Global Industry Analysis And Forecast To 2023

  Published Date :2022-06-18 Pages :190 Category : Pharmaceuticals

  The Asthma and COPD Drugs Market was worth USD 12.58 billion in 2014 and is expected to reach approximately USD 17.99 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 4.05% during the forecast period.  Asthma is an illness described by repetitive assaults of hacking, chest-fixing, windedness, and wheezing as the airways becomes thin and swell that differ in seriousness and recurrence

• Biologics Market By Product (monoclonal Antibodies, Vaccines, Recombinant Hormones/proteins, Cell Therapy, Gene Therapy, Other Products) And Application (oncology, Infectious Diseases, Immunology, Autoimmune Diseases, Other Applications) - Global Industry Analysis And Forecast To 2023

  Published Date :2022-06-18 Pages :190 Category : Pharmaceuticals

  The Biologics Market was worth USD 267.58 billion in 2014 and is expected to reach approximately USD 373.66 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 3.78% during the forecast period. Biologics are medicates as hereditarily built proteins, got from human qualities. According to the US FDA, biologics can be made out of sugars, proteins, or nucleic acids or complex blends of these substances, or might live elements, for example, cells and tissues.

• Human Insulin Market By Type [traditional Human Insulin (premixed Traditional, Intermediate Acting, Short Acting), Modern Human Insulin (premixed Modern, Long Acting, Rapid Acting) And Brand [traditional Human Insulin Brands (humulin, Actrapid, Insuman) And Modern Human Insulin Brands (humalog, Novomix, Novorapid, Lantus, Levemir, Apidra)] - Global Industry Analysis And Forecast To 2023

  Published Date :2022-06-18 Pages :190 Category : Pharmaceuticals

  The Human Insulin Market was worth USD 24.45 billion in 2014 and is expected to reach approximately USD 69.80 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 12.36% during the forecast period. Diabetes alludes to a gathering of metabolic sickness described by high glucose level.

• Silver Wound Dressing Market By Product (hydrofibre Silver Dressings, Silver Alginate Dressings, Silver Nitrate Dressings, Nano Crystalline Silver Dressings, Silver Plated Nylon Fiber Dressings, Other Products) And Application (hospitals, Ambulatory Centers, Private Clinics) - Global Industry Analysis And Forecast To 2023

  Published Date :2022-06-18 Pages :190 Category : Pharmaceuticals

  The Silver Wound Dressing Market is expected to witness considerable growth during the forecast period.  Silver injury dressings are intense against microbials and are generally used to help administration of wounds that are related with the shot of contamination.

• Anti-inflammatory Therapeutics Market By Indication (arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory/bowel Disease & Other Inflammatory Diseases) And Drug Class (anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (nsaids) & Corticosteroids)- Global Industry Analysis And Forecast To 2023

  Published Date :2022-06-18 Pages :190 Category : Pharmaceuticals

  Anti-inflammatory Therapeutics Market was worth USD 71.47 billion in 2014 and is expected to reach approximately USD 118.81 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 5.81% during the forecast period. Inflammation is a complicated reaction of the body towards damaged cells, pathogens or any external foreign material

• Generic Injectables Market By Therapeutic Area (oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition And Cardiovascular) And Distribution Channel (hospitals And Retail Pharmacy Stores) - Global Industry Analysis And Forecast To 2023

  Published Date :2022-06-18 Pages :190 Category : Pharmaceuticals

  The Generic Injectable Market is expected to showcase immense growth over the forecast period due to the presence of various driving factors.  Generic Injectable is bio-reciprocals of their marked partners which are not ensured by tranquilize licenses.

• Mitomycin Market By Product Type and Application - Global Industry Analysis And Forecast To 2027

  Published Date :2022-05-19 Pages :173 Category : Pharmaceuticals

  Mitomycin Market By Product Type (40 Mg, 10 Mg, 2 Mg and Other Product Types) and Application (Ophthalmic Use, Cancer Treatment and Other Applications) - Global Industry Analysis And Forecast To 2027,Mitomycin also referred to as the Mitomycin C is the chemotherapy medication utilized for the treatment of various cancers which include stomach, bladder, pancreas, breast, gullet (oesophagus), anal, liver and lung cancers.

• Neuroprotection Market By Product And Application- Global Industry Analysis And Forecast To 2023

  Published Date :2022-05-18 Pages :190 Category : Pharmaceuticals

  The Neuroprotection Market was has encountered substantial development in the recent years and is foreseen to grow tremendously in the following years. Neuroprotection is characterized as an association able to influence the etiology or the pathogenesis fundamental neurodegenerative infections.

• Ocular Inflammation Treatment Market By Treatment Type, Disease Type, Mode Of Administration And Distribution Channel - Global Industry Analysis And Forecast To 2023

  Published Date :2022-05-18 Pages :190 Category : Pharmaceuticals

  The Ocular Inflammation Treatment Market was worth USD 22.58 billion in 2014 and is expected to reach approximately USD 39.64 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 6.45% during the forecast period.

• Peptide Therapeutics Market By Type, Type Of Manufacturers, Route Of Administration, Application & Synthesis Technology - Global Industry Analysis And Forecast To 2023

  Published Date :2022-05-18 Pages :180 Category : Pharmaceuticals

  The Peptide Therapeutics Market was worth USD 19.52 billion in 2014 and is expected to reach approximately USD 42.97 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.16% during the forecast period.